• Purple abstract
    Dear Community Colleagues,  Last week, we informed you of the news that Mark Wilson was stepping down from his role as Chief Executive Officer (CEO) after eight years of outstanding service.  Today, we want to provide you with an update of the Governing Board's plans during this transition period for organizational leadership.  Our Editor in Chief...
    21 4月 2021
  • Featured Review: Probiotics to prevent gestational diabetes mellitus
    20 4月 2021
  • Globe and stethoscope on blue background
    Wednesday 7 April marks World Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to spotlight health equity. Health equity is the absence of avoidable and unfair differences in health. The COVID-19 pandemic and its uneven impacts worldwide has brought attention to...
    7 4月 2021
  • Group of people who helped
    Cochrane community contributes to update to the PRISMA statement. PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA primarily focuses on the reporting of reviews evaluating the effects of interventions, but can also be used as a basis for reporting systematic reviews with objectives...
    7 4月 2021
  • Heather drawing
    Interview with Heather Tubwon, the artist that created the new limited edition designs in the Cochrane store celebrating Anne Anderson and our diverse community. The global Cochrane community are participating in a virtual walk and raising money for the annual Anne Anderson Award, which is given to a Cochrane member who has contributed...
    6 4月 2021
  • Cochrane Australia vs. COVID-19: Supporting the national COVID-19 Taskforce
    In March 2020, Cochrane Australia convened the National COVID-19 Clinical Evidence Taskforce - bringing together leading health researchers, experts and organisations from across the country.

    Since then, over 240 members have worked around the clock to deliver living clinical guidelines and flowcharts for frontline health workers.  The...
    1 4月 2021
  • Artist take on Virus Cells
    Cochrane provides high-quality, relevant and up-to-date synthesized research evidence to inform health decisions. This page highlights the many ways that Cochrane has successfully responded to COVID-19 around the world. Click on any of the case studies below to find out more, and check back often as we continuously add and update new stories....
    1 4月 2021
  • Doctor at desk looking at data
    Cochrane Austria, together with TranspariMED and Transparency International Austria, has recently published a report on clinical trial transparency in Austria, which provides an update on figures released one year ago. The report uses data from the EU Trials Tracker to summarise the clinical drug trial reporting rates of the 14 largest sponsors in...
    30 3月 2021
  • People talking at table
    Register for the 'A day with... Statistics Methods Group’ which is taking place on 11 May 2021. This is part of a series of virtual events from Cochrane Training for anyone interested in systematic review methodology and the work of Cochrane Methods Groups. Whether you are new to systematic review methodology or an advanced-level learner, these...
    29 3月 2021
  • Lund University working paper illustrates how to integrate Cochrane Interactive Learning to deliver relevant evidence-based medicine learning objectives
    In the Medical Degree Program at Lund University, Sweden, a new Scientific Scholarship theme has been implemented, including evidence-based medicine (EBM), as the application of scientific scholarship in EBM is a core aspect of medical education. Throughout the program, scientific scholarship and EBM are supported by multifaceted learning...
    26 3月 2021
  • Pills and pill bottle
    During the past 12 months chloroquine and hydroxychloroquine have been touted as cures for COVID-19 and introduced into Covid-19 treatment protocols. This has led to increases in demand, leaving some rheumatoid arthritis and lupus patients deprived of effective treatments. A newly published Cochrane Library Editorial explores the story of the...
    25 3月 2021
  • chloroquine hydroxychloroquine COVID-19 visual abstract
    COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.

    Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and...
    25 3月 2021
  • Tiffany
    Watch Cochrane US Senior Officer, Tiffany Duque, as the featured guest on the Addictive Brain videocast. Tiffany spoke to  Dr. Chinmaya  Sadangi for the session called "Interview with a Scientist."  The Addictive Brain is an online community aiming at bridging the gap between science and the world in general. Their audience is mostly non-...
    24 3月 2021
  • COVID test
    Updated Cochrane review assesses how accurate rapid tests are for detecting COVID-19 Today, Cochrane published an updated systematic review assessing rapid tests for the detection of SARS-CoV-2 infection (COVID-19). The review shows that rapid antigen tests are better at correctly identifying cases of COVID-19 in people with symptoms than in...
    24 3月 2021
  • Cochrane Library release updated Special Collection on diagnosing tuberculosis
    Cochrane Library releases updated Special Collection on diagnosing tuberculosis  World Tuberculosis Day is marked annually on 24 March as it commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis. This Special Collection, curated by Cochrane contributors,...
    23 3月 2021
  • Cochrane International Mobility - Vanessa Young
    Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere. Getting involved in Cochrane’s work means becoming part of a global...
    22 3月 2021
  • Praba Sekhar and Darren Trinh
    Mindfulness has been growing in popularity across the globe over the past decade and is increasingly the subject of scientific research into the benefits it may deliver. In 2020, six students from Melbourne’s Monash University sought to better understand if and how mindfulness practice could help fellow medical students and junior doctors deal...
    18 3月 2021
  • a rendering of a human torso with blue particles circulating throughout it
    This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19.  Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment. Studies of other...
    18 3月 2021
  • Cochrane has signed a World Health Organization (WHO) Declaration that calls for a more equitable rollout of COVID-19 vaccines.

    While several countries currently have vaccination programmes up and running, the global distribution of vaccines has so far been unequal. Many low- and middle-income countries are yet to receive any doses and...
    17 3月 2021
  • Do psychosocial interventions help parents reduce how often they drink heavily or use drugs?
    17 3月 2021


Subscribe to ニュースとジョブ